Heerma Peter bought TVTX
September 15, 2026 · Form 4 insider transaction
Heerma Peter bought 39,283 shares of Travere Therapeutics, Inc. at $26.88 per share, a transaction worth $1.06M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
39,283
Price
$26.88
Total value
$1.06M
InsiderHeerma Peter
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after181,349
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 1,382 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.